We found 601 records for "Regulatory / compliance"

Articles

Tunnah’s musings: building the right relationship between patients and pharma

28th May 2015

 Tunnah’s musings: building the right relationship between patients and pharmaArticles

This month, Paul Tunnah is cautiously optimistic that the value of engaging with patients is starting to be recognised across the pharmaceutical industry, but muses on how this should be...

Read more

Data, ethics and anonymisation in a changing digital communications world

19th May 2015

 Data, ethics and anonymisation in a changing digital communications worldArticles

This is the last in a series of three articles examining the legal and ethical dilemmas faced when using new mediums and data sources for healthcare market research and data...

Read more

A new era of transparency: UK pharma prepares to publish doctor payments

5th May 2015

 A new era of transparency: UK pharma prepares to publish doctor paymentsArticles

Pharma companies across Europe are gearing up to disclose for the first time the names of health professionals and healthcare organisations who they have made payments to. In the first...

Read more

Market access for specialist medicines in the UK: the Price is Right?

5th May 2015

 Market access for specialist medicines in the UK: the Price is Right?Articles

A recent pharmaphorum webinar brought four experts together to discuss the future of market access for specialist medicines in the UK. IMS Health's Angela McFarlane, Shire's Alan Kane, the Cystic...

Read more

News

Teva pays $1.2bn to settle pay-for-delay deal

29th May 2015

 Teva pays $1.2bn to settle pay-for-delay dealNews

Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil.In a...

Read more

PD-1 inhibitors head latest crop of CHMP opinions

27th May 2015

 PD-1 inhibitors head latest crop of CHMP opinionsNews

Eight new drugs were recommended for approval at the CHMP's latest meeting, with cancer immunotherapies from Merck & Co and Bristol-Myers Squibb (BMS) headlining.Merck's Keytruda (pembrolizumab) was given a green...

Read more

All but one Cancer Drug Fund appeals rejected

26th May 2015

 All but one Cancer Drug Fund appeals rejectedNews

Of the four companies that appealed the removal of their drugs from the UK's Cancer Drugs Fund, only Bayer successfully overturned the decision.NHS England has agreed to restore Bayer's stomach...

Read more

NICE to launch ‘Office for Market Access’

22nd May 2015

 NICE to launch ‘Office for Market Access’News

NICE is to establish a new Office for Market Access to help life sciences companies prepare for its cost effectiveness appraisals and improve their chances of gaining a 'yes'.The new...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Real World Evidence Europe 2015

3rd June 2015 - 4th June 2015

Real World Evidence Europe 2015

Real World Evidence Europe, now in its 3rd year, gathers Europe’s top thought leaders in the RWE space with case studies, panel discussions, networking and expert speakers from Pfizer, Sanofi,...

Read more

Market Access & Pricing Excellence

3rd June 2015 - 4th June 2015

Market Access & Pricing Excellence

Market Access & Pricing Excellence 2015 is Europe’s most comprehensive pharma access & pricing summit, with 3 unique tracks focusing on Operational Excellence, HTA & Policy and Real World Evidence....

Read more

Joint DIA/EMA Information Day on Post-Authorisation Studies (PAS)

5th June 2015

Joint DIA/EMA Information Day on Post-Authorisation Studies (PAS)

This information day on post-authorisation studies (PAS) and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is targeted to industry, academia and CROs as main stakeholders. The objective...

Read more

Patient Centric Clinical Trials Europe

8th June 2015 - 9th June 2015

Patient Centric Clinical Trials Europe

This high-level, two-day meeting is purpose-built to give you a roadmap to making your clinical trials more patient-centric.   By attending, you’ll find out how to engage better with patients, improve...

Read more

Press Releases

The REAL WORLD Challenge: Are you maximising the effectiveness of RWE?

20th April 2015

The REAL WORLD Challenge: Are you maximising the effectiveness of RWE?

RWE is now recognised as critical to all commercial activities and is becoming embedded across the life-science industry. pH Associates is hosting a summit on May 5th (4-7pm) that will take a fresh look...

Read more

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

15th April 2015

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

  The eagerly awaited second edition of Arthur G. Cook's Forecasting for the Pharmaceutical Industry is now available from Gower.     Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as...

Read more

Veeva Systems Introduces Veeva OpenKey

24th March 2015

Veeva Systems Introduces Veeva OpenKey

  Veeva Systems has launched Veeva OpenKey, a new type of customer data solution for the life sciences industry.  As the life sciences business continues to diversify across borders and new channels,...

Read more

Adelphi Research UK Refreshes Corporate Brand & Positioning

4th March 2015

Adelphi Research UK Refreshes Corporate Brand & Positioning

    Adelphi Research UK has a strong heritage of providing robust market research in the healthcare sector. Established since 2000, they have extensive expertise in pharma, and also span OTC and...

Read more